| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infertility, Female | 19 | 2022 | 42 | 4.110 |
Why?
|
| Infertility | 10 | 2022 | 35 | 3.820 |
Why?
|
| Ovulation Induction | 14 | 2022 | 33 | 3.120 |
Why?
|
| Ovarian Follicle | 10 | 2019 | 84 | 2.660 |
Why?
|
| Live Birth | 14 | 2021 | 39 | 2.540 |
Why?
|
| Polycystic Ovary Syndrome | 14 | 2022 | 63 | 1.780 |
Why?
|
| Insemination, Artificial | 8 | 2022 | 23 | 1.670 |
Why?
|
| Pregnancy | 32 | 2022 | 1130 | 1.650 |
Why?
|
| Infertility, Male | 8 | 2022 | 23 | 1.640 |
Why?
|
| Aging | 11 | 2019 | 954 | 1.310 |
Why?
|
| Watchful Waiting | 4 | 2022 | 18 | 1.310 |
Why?
|
| Female | 58 | 2022 | 14462 | 1.300 |
Why?
|
| Fertility | 8 | 2022 | 58 | 1.270 |
Why?
|
| Pregnancy Rate | 16 | 2022 | 45 | 1.260 |
Why?
|
| Fertility Agents, Female | 8 | 2022 | 15 | 1.260 |
Why?
|
| Luteal Phase | 2 | 2019 | 7 | 1.260 |
Why?
|
| Progesterone | 3 | 2019 | 128 | 1.180 |
Why?
|
| Pregnancy, Ectopic | 4 | 2021 | 11 | 1.160 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 3 | 2021 | 5 | 1.130 |
Why?
|
| Reproduction | 4 | 2012 | 63 | 1.110 |
Why?
|
| Humans | 66 | 2022 | 26856 | 1.010 |
Why?
|
| Adult | 43 | 2022 | 7389 | 0.970 |
Why?
|
| Ovary | 3 | 2013 | 69 | 0.950 |
Why?
|
| Reproductive Techniques, Assisted | 5 | 2021 | 17 | 0.930 |
Why?
|
| Hysterosalpingography | 2 | 2020 | 4 | 0.860 |
Why?
|
| Embryo Transfer | 3 | 2021 | 13 | 0.850 |
Why?
|
| Fertilization in Vitro | 6 | 2021 | 24 | 0.820 |
Why?
|
| Proprotein Convertases | 1 | 2022 | 11 | 0.800 |
Why?
|
| Models, Biological | 3 | 2014 | 446 | 0.800 |
Why?
|
| Prospective Studies | 14 | 2022 | 1219 | 0.800 |
Why?
|
| Insulin Resistance | 3 | 2022 | 165 | 0.790 |
Why?
|
| Life Style | 3 | 2022 | 82 | 0.770 |
Why?
|
| Progestins | 2 | 2019 | 10 | 0.760 |
Why?
|
| Cryopreservation | 2 | 2021 | 12 | 0.740 |
Why?
|
| Ovarian Reserve | 2 | 2019 | 9 | 0.680 |
Why?
|
| Ultrasonography | 6 | 2018 | 228 | 0.670 |
Why?
|
| Gonadotropins | 5 | 2020 | 22 | 0.640 |
Why?
|
| Biomarkers | 8 | 2022 | 731 | 0.620 |
Why?
|
| Estradiol | 4 | 2014 | 174 | 0.610 |
Why?
|
| Chorionic Gonadotropin | 3 | 2021 | 22 | 0.570 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2016 | 24 | 0.540 |
Why?
|
| Pregnancy Outcome | 6 | 2021 | 128 | 0.540 |
Why?
|
| Obesity | 6 | 2022 | 647 | 0.530 |
Why?
|
| Clomiphene | 5 | 2021 | 11 | 0.520 |
Why?
|
| Premenopause | 1 | 2015 | 20 | 0.500 |
Why?
|
| Off-Label Use | 1 | 2015 | 6 | 0.490 |
Why?
|
| Drug Labeling | 1 | 2015 | 4 | 0.490 |
Why?
|
| Endometriosis | 1 | 2015 | 19 | 0.480 |
Why?
|
| Birth Rate | 1 | 2014 | 11 | 0.480 |
Why?
|
| Drug Prescriptions | 1 | 2015 | 43 | 0.480 |
Why?
|
| Follicle Stimulating Hormone | 4 | 2012 | 71 | 0.470 |
Why?
|
| Ovariectomy | 2 | 2012 | 53 | 0.440 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2013 | 6 | 0.440 |
Why?
|
| Semen | 3 | 2022 | 27 | 0.420 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 140 | 0.410 |
Why?
|
| Treatment Outcome | 11 | 2022 | 2267 | 0.410 |
Why?
|
| Abortion, Spontaneous | 3 | 2021 | 15 | 0.400 |
Why?
|
| Spermatozoa | 3 | 2022 | 28 | 0.390 |
Why?
|
| Young Adult | 15 | 2022 | 2584 | 0.380 |
Why?
|
| Pregnancy, Multiple | 3 | 2015 | 8 | 0.380 |
Why?
|
| Male | 19 | 2022 | 12866 | 0.380 |
Why?
|
| Insemination | 2 | 2020 | 6 | 0.350 |
Why?
|
| Methotrexate | 2 | 2021 | 31 | 0.350 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2022 | 358 | 0.330 |
Why?
|
| 5'-Nucleotidase | 4 | 2002 | 13 | 0.320 |
Why?
|
| Body Mass Index | 5 | 2022 | 384 | 0.320 |
Why?
|
| Antioxidants | 2 | 2021 | 222 | 0.310 |
Why?
|
| Inhibins | 4 | 2012 | 8 | 0.310 |
Why?
|
| Follicular Phase | 2 | 2004 | 8 | 0.300 |
Why?
|
| Middle Aged | 10 | 2019 | 6825 | 0.300 |
Why?
|
| Adolescent | 13 | 2021 | 2960 | 0.290 |
Why?
|
| United States | 8 | 2022 | 2035 | 0.270 |
Why?
|
| Sperm Count | 3 | 2022 | 13 | 0.270 |
Why?
|
| Triazoles | 2 | 2015 | 14 | 0.250 |
Why?
|
| Nitriles | 2 | 2015 | 32 | 0.250 |
Why?
|
| Risk Factors | 7 | 2022 | 2017 | 0.240 |
Why?
|
| Patient Selection | 2 | 2015 | 143 | 0.240 |
Why?
|
| Triglycerides | 2 | 2022 | 116 | 0.230 |
Why?
|
| Galanin-Like Peptide | 1 | 2003 | 1 | 0.220 |
Why?
|
| Infant, Newborn | 4 | 2020 | 848 | 0.220 |
Why?
|
| Sympathetic Nervous System | 1 | 2003 | 64 | 0.210 |
Why?
|
| Metabolic Syndrome | 2 | 2021 | 77 | 0.210 |
Why?
|
| Insemination, Artificial, Homologous | 2 | 2020 | 4 | 0.210 |
Why?
|
| Dilatation and Curettage | 2 | 2021 | 4 | 0.210 |
Why?
|
| Proprotein Convertase 9 | 1 | 2022 | 3 | 0.200 |
Why?
|
| Androgens | 2 | 2020 | 47 | 0.200 |
Why?
|
| Chi-Square Distribution | 4 | 2015 | 144 | 0.200 |
Why?
|
| Subtilisins | 1 | 2022 | 6 | 0.200 |
Why?
|
| Cholesterol, LDL | 1 | 2022 | 65 | 0.200 |
Why?
|
| Testosterone | 2 | 2019 | 68 | 0.200 |
Why?
|
| Predictive Value of Tests | 3 | 2016 | 472 | 0.190 |
Why?
|
| Decision Support Techniques | 1 | 2022 | 49 | 0.190 |
Why?
|
| Lipoproteins | 1 | 2022 | 95 | 0.190 |
Why?
|
| Retrospective Studies | 5 | 2021 | 2444 | 0.190 |
Why?
|
| Cohort Studies | 5 | 2022 | 860 | 0.190 |
Why?
|
| Vitamins | 1 | 2021 | 22 | 0.190 |
Why?
|
| Hydrocortisone | 1 | 2022 | 88 | 0.190 |
Why?
|
| Anti-Mullerian Hormone | 2 | 2012 | 6 | 0.190 |
Why?
|
| Precision Medicine | 1 | 2022 | 67 | 0.190 |
Why?
|
| Sleep | 1 | 2021 | 100 | 0.180 |
Why?
|
| Cholesterol | 1 | 2022 | 181 | 0.180 |
Why?
|
| Endometrium | 1 | 2020 | 38 | 0.180 |
Why?
|
| Ethiodized Oil | 1 | 2020 | 2 | 0.180 |
Why?
|
| Fertility Agents | 1 | 2020 | 2 | 0.180 |
Why?
|
| Surveys and Questionnaires | 3 | 2021 | 917 | 0.180 |
Why?
|
| Gonadotropin-Releasing Hormone | 2 | 2015 | 37 | 0.170 |
Why?
|
| Fertilization | 2 | 2022 | 9 | 0.170 |
Why?
|
| Child Behavior | 1 | 2020 | 26 | 0.170 |
Why?
|
| Child | 3 | 2020 | 2152 | 0.170 |
Why?
|
| Pregnancy Complications | 1 | 2021 | 105 | 0.170 |
Why?
|
| BRCA2 Protein | 1 | 2019 | 18 | 0.170 |
Why?
|
| Reproductive Medicine | 2 | 2018 | 4 | 0.170 |
Why?
|
| Metformin | 1 | 2020 | 32 | 0.170 |
Why?
|
| BRCA1 Protein | 1 | 2019 | 23 | 0.170 |
Why?
|
| Contrast Media | 1 | 2020 | 93 | 0.170 |
Why?
|
| Fallopian Tubes | 2 | 2018 | 14 | 0.170 |
Why?
|
| Erectile Dysfunction | 1 | 2019 | 13 | 0.170 |
Why?
|
| Water | 1 | 2020 | 131 | 0.160 |
Why?
|
| Ovulation | 2 | 2018 | 28 | 0.160 |
Why?
|
| Spermatogenesis | 1 | 2019 | 11 | 0.160 |
Why?
|
| Leiomyoma | 1 | 2019 | 9 | 0.160 |
Why?
|
| Child Development | 1 | 2020 | 71 | 0.160 |
Why?
|
| Endocrinologists | 1 | 2019 | 2 | 0.160 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2018 | 2 | 0.160 |
Why?
|
| Ethics Committees, Research | 1 | 2018 | 6 | 0.160 |
Why?
|
| Clinical Protocols | 1 | 2018 | 45 | 0.160 |
Why?
|
| Pre-Eclampsia | 1 | 2018 | 48 | 0.150 |
Why?
|
| Gynecology | 1 | 2019 | 55 | 0.150 |
Why?
|
| Menstrual Cycle | 2 | 2012 | 22 | 0.150 |
Why?
|
| Antidepressive Agents | 1 | 2018 | 29 | 0.150 |
Why?
|
| Reproducibility of Results | 3 | 2010 | 748 | 0.150 |
Why?
|
| Vitamin D | 1 | 2018 | 44 | 0.150 |
Why?
|
| Vitamin D Deficiency | 1 | 2018 | 27 | 0.150 |
Why?
|
| Transcriptome | 1 | 2019 | 198 | 0.150 |
Why?
|
| Quality of Life | 2 | 2019 | 463 | 0.150 |
Why?
|
| Diabetes, Gestational | 1 | 2018 | 63 | 0.150 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2017 | 6 | 0.140 |
Why?
|
| Depression | 1 | 2019 | 210 | 0.140 |
Why?
|
| Semen Analysis | 3 | 2022 | 9 | 0.140 |
Why?
|
| Oxidative Stress | 1 | 2021 | 619 | 0.140 |
Why?
|
| Depressive Disorder, Major | 1 | 2018 | 125 | 0.130 |
Why?
|
| Alcohol Drinking | 2 | 2015 | 162 | 0.130 |
Why?
|
| Contraceptives, Oral | 1 | 2015 | 22 | 0.130 |
Why?
|
| Chlamydia trachomatis | 1 | 2015 | 16 | 0.130 |
Why?
|
| Chlamydia Infections | 1 | 2015 | 17 | 0.130 |
Why?
|
| Multicenter Studies as Topic | 3 | 2021 | 42 | 0.130 |
Why?
|
| Patient Dropouts | 1 | 2015 | 6 | 0.130 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 915 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 2 | 2002 | 332 | 0.130 |
Why?
|
| Ovulation Inhibition | 1 | 2015 | 1 | 0.120 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2015 | 9 | 0.120 |
Why?
|
| Referral and Consultation | 1 | 2015 | 87 | 0.120 |
Why?
|
| Organ Size | 2 | 2020 | 82 | 0.120 |
Why?
|
| Antibodies, Bacterial | 1 | 2015 | 100 | 0.120 |
Why?
|
| United States Food and Drug Administration | 1 | 2015 | 43 | 0.120 |
Why?
|
| Time Factors | 2 | 2018 | 1564 | 0.120 |
Why?
|
| Models, Theoretical | 1 | 2015 | 129 | 0.120 |
Why?
|
| Case-Control Studies | 3 | 2018 | 701 | 0.110 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1994 | 26 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 447 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2014 | 388 | 0.110 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 266 | 0.110 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 2013 | 4 | 0.110 |
Why?
|
| Protein Biosynthesis | 1 | 1994 | 106 | 0.110 |
Why?
|
| Preoperative Care | 1 | 2013 | 76 | 0.110 |
Why?
|
| Research Design | 2 | 2019 | 173 | 0.110 |
Why?
|
| Prevalence | 3 | 2019 | 469 | 0.100 |
Why?
|
| Risk Assessment | 4 | 2022 | 586 | 0.100 |
Why?
|
| Congresses as Topic | 1 | 2012 | 32 | 0.100 |
Why?
|
| Smoking | 1 | 2015 | 466 | 0.090 |
Why?
|
| Infant | 2 | 2020 | 963 | 0.090 |
Why?
|
| Down-Regulation | 2 | 2019 | 196 | 0.090 |
Why?
|
| Child, Preschool | 2 | 2020 | 1090 | 0.090 |
Why?
|
| Sperm Motility | 2 | 2022 | 10 | 0.090 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 981 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2003 | 645 | 0.080 |
Why?
|
| Multivariate Analysis | 3 | 2015 | 297 | 0.080 |
Why?
|
| Recombinant Proteins | 2 | 2004 | 408 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 802 | 0.080 |
Why?
|
| Double-Blind Method | 2 | 2020 | 399 | 0.080 |
Why?
|
| Anthropometry | 1 | 2008 | 94 | 0.070 |
Why?
|
| Hyperandrogenism | 2 | 2018 | 11 | 0.070 |
Why?
|
| Observer Variation | 2 | 2007 | 43 | 0.070 |
Why?
|
| Hydronephrosis | 1 | 2007 | 11 | 0.070 |
Why?
|
| Ureteral Obstruction | 1 | 2007 | 12 | 0.070 |
Why?
|
| Animals | 4 | 2013 | 9954 | 0.070 |
Why?
|
| Base Sequence | 4 | 1995 | 573 | 0.070 |
Why?
|
| Stents | 1 | 2007 | 114 | 0.070 |
Why?
|
| Cloning, Molecular | 3 | 1995 | 205 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 1995 | 1036 | 0.060 |
Why?
|
| Prognosis | 2 | 2020 | 758 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 246 | 0.060 |
Why?
|
| Phenotype | 2 | 2018 | 664 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2015 | 231 | 0.060 |
Why?
|
| Inhibin-beta Subunits | 1 | 2004 | 3 | 0.060 |
Why?
|
| Activins | 1 | 2004 | 4 | 0.060 |
Why?
|
| Injections, Intraventricular | 1 | 2003 | 7 | 0.060 |
Why?
|
| Metabolism | 1 | 2003 | 9 | 0.060 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2003 | 5 | 0.060 |
Why?
|
| Uncoupling Protein 1 | 1 | 2003 | 13 | 0.050 |
Why?
|
| Pituitary Gland | 1 | 2003 | 53 | 0.050 |
Why?
|
| Academic Medical Centers | 2 | 2015 | 73 | 0.050 |
Why?
|
| Ion Channels | 1 | 2003 | 22 | 0.050 |
Why?
|
| Adipose Tissue, Brown | 1 | 2003 | 13 | 0.050 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2003 | 14 | 0.050 |
Why?
|
| Reference Values | 1 | 2003 | 198 | 0.050 |
Why?
|
| Eating | 1 | 2003 | 66 | 0.050 |
Why?
|
| Leptin | 1 | 2003 | 66 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2003 | 70 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 218 | 0.050 |
Why?
|
| Logistic Models | 2 | 2015 | 397 | 0.050 |
Why?
|
| Body Weight | 1 | 2003 | 245 | 0.050 |
Why?
|
| alpha-Amylases | 1 | 2022 | 2 | 0.050 |
Why?
|
| Coitus | 1 | 2022 | 14 | 0.050 |
Why?
|
| Maternal Age | 1 | 2022 | 25 | 0.050 |
Why?
|
| Snoring | 1 | 2021 | 8 | 0.050 |
Why?
|
| Preconception Care | 1 | 2022 | 17 | 0.050 |
Why?
|
| Uterine Hemorrhage | 1 | 2021 | 9 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2003 | 245 | 0.050 |
Why?
|
| Clinical Decision-Making | 1 | 2022 | 61 | 0.050 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2021 | 36 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2002 | 186 | 0.050 |
Why?
|
| Weight Loss | 1 | 2022 | 71 | 0.050 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2021 | 38 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2019 | 453 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2021 | 89 | 0.050 |
Why?
|
| Sleep Wake Disorders | 1 | 2021 | 65 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 290 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 245 | 0.040 |
Why?
|
| Family Characteristics | 1 | 2020 | 46 | 0.040 |
Why?
|
| Gestures | 1 | 2020 | 1 | 0.040 |
Why?
|
| Rats | 1 | 2003 | 1536 | 0.040 |
Why?
|
| Heterozygote | 1 | 2019 | 64 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2019 | 31 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2003 | 466 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2019 | 53 | 0.040 |
Why?
|
| Weight Gain | 1 | 2020 | 73 | 0.040 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2019 | 20 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2019 | 21 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 75 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 105 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 482 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2002 | 511 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2003 | 1474 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2020 | 391 | 0.040 |
Why?
|
| Birth Weight | 1 | 2018 | 63 | 0.040 |
Why?
|
| Registries | 1 | 2020 | 383 | 0.040 |
Why?
|
| Asian Americans | 1 | 2018 | 40 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2019 | 149 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 716 | 0.040 |
Why?
|
| Exercise | 1 | 2022 | 451 | 0.040 |
Why?
|
| Mice | 3 | 2003 | 4402 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 368 | 0.040 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2017 | 4 | 0.040 |
Why?
|
| Cognition | 1 | 2020 | 294 | 0.040 |
Why?
|
| Hirsutism | 1 | 2017 | 17 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2017 | 18 | 0.030 |
Why?
|
| Hypertriglyceridemia | 1 | 2017 | 8 | 0.030 |
Why?
|
| Laparoscopy | 1 | 2018 | 143 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 1995 | 399 | 0.030 |
Why?
|
| Adenosine Deaminase | 1 | 1995 | 5 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1995 | 65 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2015 | 19 | 0.030 |
Why?
|
| Receptors, Purinergic P1 | 1 | 1995 | 2 | 0.030 |
Why?
|
| Base Composition | 1 | 1995 | 107 | 0.030 |
Why?
|
| African Americans | 1 | 2018 | 348 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1995 | 93 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2017 | 300 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 202 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 254 | 0.030 |
Why?
|
| Binding Sites | 1 | 1995 | 338 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 203 | 0.030 |
Why?
|
| Antibodies | 1 | 1995 | 124 | 0.030 |
Why?
|
| Internet | 1 | 2015 | 121 | 0.030 |
Why?
|
| RNA Caps | 1 | 1994 | 2 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1994 | 20 | 0.030 |
Why?
|
| Genomic Library | 1 | 1994 | 10 | 0.030 |
Why?
|
| Gene Amplification | 1 | 1994 | 22 | 0.030 |
Why?
|
| Orchiectomy | 1 | 2013 | 12 | 0.030 |
Why?
|
| Epididymis | 1 | 2013 | 5 | 0.030 |
Why?
|
| Indians, North American | 1 | 2018 | 508 | 0.030 |
Why?
|
| Placenta | 1 | 1994 | 74 | 0.030 |
Why?
|
| Superovulation | 1 | 2012 | 6 | 0.020 |
Why?
|
| Alcoholic Beverages | 1 | 2012 | 4 | 0.020 |
Why?
|
| Coffee | 1 | 2012 | 5 | 0.020 |
Why?
|
| Tea | 1 | 2012 | 7 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2012 | 40 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2007 | 34 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2007 | 119 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1995 | 130 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 2004 | 57 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1995 | 674 | 0.010 |
Why?
|
| Apyrase | 1 | 2002 | 4 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2002 | 11 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2002 | 25 | 0.010 |
Why?
|
| Permeability | 1 | 2002 | 58 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2002 | 35 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2002 | 47 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2002 | 57 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2002 | 134 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2002 | 969 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2002 | 624 | 0.010 |
Why?
|
| Chickens | 1 | 1995 | 59 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1995 | 75 | 0.010 |
Why?
|
| DNA Primers | 1 | 1995 | 143 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1995 | 264 | 0.010 |
Why?
|
| Ribonucleases | 1 | 1993 | 9 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1995 | 197 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1993 | 81 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1995 | 503 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1993 | 262 | 0.010 |
Why?
|
| DNA | 1 | 1993 | 365 | 0.010 |
Why?
|